Webinar Recording: HIV Testing Technologies – Choosing an HIV Test

APLA-Shared ActionHD produced the webinar“HIV Testing Technologies: Choosing an HIV Test,” presented by Dr. Bernard M. Branson, a leading expert in the area of HIV testing. The webinar described general principles of HIV tests, provided an overview of how tests operate, addressed any limitations and misconceptions of HIV tests currently available, and discussed how the various tests differ.

New FREE Continuing Education from MMWR and Medscape: HIV Testing and Diagnosis Delays

CDC’s MMWR and Medscape are proud to introduce a new FREE continuing education (CE) activity that describes diagnosis delays among persons infected with HIV: Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays — United States. This activity is intended for infectious disease clinicians, family medicine specialists, internists, nurses, pharmacists, public health officials, and other clinicians caring for patients with or at risk for HIV infection.

Webinar: After Repeal and Replace: Navigating Healthcare Access and Coverage in a Volatile 2018 Marketplace

After a year of repeal and replace efforts in Congress, enrollees and community advocates are preparing for the 2018 health care open enrollment period. With substantially higher premiums, health plan exits, uncertainty around subsidies, shorter enrollment periods, and less money being spent on advertising, 2018 is projected to present new barriers to ensuring access to healthcare.

National Online PrEP Focus Group

HealthHIV invites prescribing providers (MDs, DOs, NPs, PAs) nationwide to participate in a 20-minute online focus group to discuss HIV prevention & PrEP. Friday, August 4, 2017 12:00 PM EST Providers interested in participating can register online. PrEP, for Pre-Exposure Prophylaxis, is an important tool in the fight against HIV.

PrEP for HIV in Texas

Texas Medical Association (TMA) spotlighted the physician’s role in providing Pre-exposure Prophylaxis (PrEP) and provided in depth information on access to, efficacy of and target groups for PrEP. While treatment for an STD might be conversation starter about PrEP, PrEP is not just for STD clinicians. Primary care physicians, Ob/Gyn specialists, and others may all … Continue reading PrEP for HIV in Texas

Request for Application for Routine HIV Screening in Healthcare Settings

The DSHS HIV/STD Prevention and Care Branch announces this Request for Application (RFA) to provide sustainable, integrated, routine, opt-out screening for HIV in healthcare settings in hospital systems emergency services and primary care in community health centers that serve under- and uninsured populations in high morbidity areas in Texas.

New study finds efficacy for ART/PrEP combo

A recent study has demonstrated support for the use of a combination of ART and PrEP therapy in serodiscordant heterosexual couples in Kenya and Uganda. Heterosexual contact is the primary mode of transmission in Africa and the implementation of this approach could drastically reduce HIV.